KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to -$5.9 million.

  • ClearPoint Neuro's Consolidated Net Income fell 1843.59% to -$5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.4 million, marking a year-over-year decrease of 2834.27%. This contributed to the annual value of -$19.7 million for FY2024, which is 1202.89% up from last year.
  • ClearPoint Neuro's Consolidated Net Income amounted to -$5.9 million in Q3 2025, which was down 1843.59% from -$5.8 million recorded in Q2 2025.
  • ClearPoint Neuro's Consolidated Net Income's 5-year high stood at -$2.5 million during Q1 2021, with a 5-year trough of -$7.1 million in Q2 2023.
  • For the 5-year period, ClearPoint Neuro's Consolidated Net Income averaged around -$4.7 million, with its median value being -$4.5 million (2022).
  • In the last 5 years, ClearPoint Neuro's Consolidated Net Income plummeted by 15829.39% in 2021 and then skyrocketed by 3818.54% in 2024.
  • Quarter analysis of 5 years shows ClearPoint Neuro's Consolidated Net Income stood at -$4.0 million in 2021, then decreased by 12.23% to -$4.5 million in 2022, then fell by 5.3% to -$4.7 million in 2023, then fell by 20.02% to -$5.6 million in 2024, then dropped by 4.3% to -$5.9 million in 2025.
  • Its Consolidated Net Income was -$5.9 million in Q3 2025, compared to -$5.8 million in Q2 2025 and -$6.0 million in Q1 2025.